China NMPA approves Rona Therapeutics’ IND application for RN1871, a novel AGT-targeting siRNA drug for hypertension

Join Pharma | Login

	Editorial


	MAKE PIC/S DREAM A REALITY
	Wednesday, April 16, 2025
	The Indian pharmaceutical industry has long been supplying over 50 per cent of global demand for various vaccines, 40 per cent of generic demand in the US and 25 per cent of all medicines in the UK.
	Past Editorial...

TODAY'S NEWS


18:00 [IST]	China NMPA approves Rona Therapeutics’ IND application for RN1871, a novel AGT-targeting siRNA drug for hypertension
17:00 [IST]	Roche to invest USD 50 billion in pharmaceuticals and diagnostics in the US over the next five years
16:00 [IST]	Zimmer Biomet completes acquisition of medical device company, Paragon 28
15:00 [IST]	ToolGen files patent infringement lawsuit against Vertex Pharma in UK for genome editing therapy CASGEVY
14:15 [IST]	Dr Batra’s Healthcare expands global footprint with launch of a virtual Homoeopathy clinic in Malaysia
14:00 [IST]	Alumis and Acelyrin announce amended merger agreement

more news >>

TOP NEWS


08:00 [IST]	Bulk drug imports decline 15.7 per cent in February
08:00 [IST]	IPA seeks clarification from DCGI on notification restricting use of FDC for common cold in infants below 4 years
08:00 [IST]	India’s nutraceutical industry gains global credibility driven by demand for ayurvedic & botanical ingredients
08:00 [IST]	India initiates crucial oral hearing in anti-dumping probe on TDI imports from EU & Saudi Arabia
08:00 [IST]	Pharma companies bolster research on new vaccines & drugs as healthcare industry is alarmed over rise in rabies
08:00 [IST]	Pharmaceuticals exports grow 9.4 per cent in FY25

more news >>

YESTERDAY'S NEWS


17:20 [IST]	Gleneagles Hospital, Parel, organizes a campaign with ‘Food is Medicine’ session on World Liver Day
16:50 [IST]	Doctors urge dietary action as India faces the world’s highest liver disease burden
16:40 [IST]	AbbVie expands global oncology footprint in India with launch of Venetoclax
15:45 [IST]	Paras Defence to manufacture critical magnets for India’s first indigenous MRI machines under SAMEER-led consortium
15:30 [IST]	Vgenomics & Meril Genomics collaborate to revolutionize precision medicine in India
15:15 [IST]	Wolters Kluwer empowers medical research in India with Ovid as part of One Nation One Subscription

more news >>

INTERVIEW


All DIs in TN are fully competent to inspect manufacturing units as per Revised Schedule M: MN Sridhar
MN Sridhar, director of the Tamil Nadu Drugs Control Department

Past Interviews...

	What's New?

Methotrexate 2.5 Mg Tab/cap Fluvoxamine 100mg Tab Vitamin D3 Inj -600000 Iu-1 Ml. Tab Tianeptine 12.5 Mg Tab.citicoline 500 Mg + Piracetam 400 Mg

Opinion Poll

Will the introduction of Revised Schedule M by Union Health Ministry solve the issue of quality of Indian drugs?

YesNoCan't Say

View Past Poll

Corporate

Special Features

Features

Chronicle Pharmabiz Specials

Forthcoming Events

TENDERS & PROJECTS

	Tenders & Enquiries
	Pharma Projects

CORPORATE

	Company Profile
	Corporate Results
	Corporate X-ray
	Pharmabiz Studies of Top Companies

US FDA UPDATE

EXPORT & IMPORT

	Drug Export Procedures
	Drug Units With WHO GMP Certification
	Pharma Export Data
	Import Reg. Update

PHARMA LAWS & DOCUMENTS

LIST OF LABS & GOVT. BODIES

	Govt Recognised In-House R&D Units
	AICTE Boards & Committees
	List of Indian CROs
	List of CROs (International)
	Govt & approved labs of India
	List of State Drugs Controllers